VANCOUVER, British Columbia, Feb. 25, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA therapeutics, announced that recent advances in the enablement of messenger RNA (mRNA) using Tekmira's lipid nanoparticle (LNP) technology were presented by Tekmira's Chief Technical Officer, Dr. Ian MacLachlan, at the AsiaTIDES Conference taking place in Tokyo, Japan from February 25-27, 2014.
Help employers find you! Check out all the jobs and post your resume.
